−0.18 EUR
−4.66 M EUR
8.00 M EUR
6.91 M
About PANGAEA ONCOLOGY S.A.
Sector
Industry
CEO
Javier Rodríguez Rivela
Website
Headquarters
Barcelona
Founded
2006
ISIN
ES0105221008
FIGI
BBG00FN9QNT1
Pangaea Oncology SA engages in the provision of molecular diagnostics and research development for cancer treatment. The company was founded by Jose Maestre, Santiago Ramon y Cajal, Rafael Rosell and Javier Rivela in 2006 and is headquartered in Barcelona, Spain.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PANG is 1.78 EUR — it has increased by 2.30% in the past 24 hours. Watch PANGAEA ONCOLOGY S.A. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BME exchange PANGAEA ONCOLOGY S.A. stocks are traded under the ticker PANG.
PANG stock has risen by 3.49% compared to the previous week, the month change is a −1.11% fall, over the last year PANGAEA ONCOLOGY S.A. has showed a −4.30% decrease.
PANG reached its all-time high on Jan 4, 2017 with the price of 3.13 EUR, and its all-time low was 0.96 EUR and was reached on Aug 11, 2020. View more price dynamics on PANG chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PANG stock is 2.29% volatile and has beta coefficient of 0.23. Track PANGAEA ONCOLOGY S.A. stock price on the chart and check out the list of the most volatile stocks — is PANGAEA ONCOLOGY S.A. there?
Yes, you can track PANGAEA ONCOLOGY S.A. financials in yearly and quarterly reports right on TradingView.
PANG net income for the last half-year is −1.60 M EUR, while the previous report showed −3.74 M EUR of net income which accounts for 57.19% change. Track more PANGAEA ONCOLOGY S.A. financial stats to get the full picture.
No, PANG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 61.00 employees. See our rating of the largest employees — is PANGAEA ONCOLOGY S.A. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PANGAEA ONCOLOGY S.A. EBITDA is −2.18 M EUR, and current EBITDA margin is −38.06%. See more stats in PANGAEA ONCOLOGY S.A. financial statements.
Like other stocks, PANG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PANGAEA ONCOLOGY S.A. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PANGAEA ONCOLOGY S.A. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PANGAEA ONCOLOGY S.A. stock shows the sell signal. See more of PANGAEA ONCOLOGY S.A. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.